Imu Biosciences
Unlocking the potential of the immune system.
$53M Series A ·
Led by IQ Capital · Source: fundraisingfox.com
Total raised: $67.66M across 2 sourced rounds
All 2 rounds ↓Signals
About Imu Biosciences
IMU's cutting-edge platform decodes complex immune challenges to drive breakthroughs and better health outcomes.
Imu Biosciences | 537 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $53M | fundraisingfox.com | ||
| Series A | $14.66M | morningstar.com |
Timeline
- Website created
Founders and team
AL
Adam Laing Co-founder & Chief Scientific OfficerLinkedIn · source: imubiosciences.comMC
Mario Cantero MBA Co-founder & Chief Operating OfficerLinkedIn · source: imubiosciences.comTH
Thomas Hayday Co-founder & Chief Research OfficerLinkedIn · source: imubiosciences.comJB
John Baker CEOTH
Timothy Haines Non Executive Chair
Investors
BBeaumont Capital
BBritish Business Bank
CCOREangelslead investor
EExpa
IIQ Capitallead investor
LLife Extension Ventures
MMeltwind Advisory
MMolten Ventureslead investor
Companies like Imu Biosciences
OOptura$17.5M Series A · May 2026
NNanoligent$14.01M Seed · Oct 2025
VViven$35M Seed · Oct 2025
FFirst Due$355M · Aug 2025
SSeismic Hazard and Risk InvestigationsSeed · Aug 2026
EEpilepsy GTx$33M Series A · Dec 2025
Other companies backed by IQ Capital
UUndecimal Bio$18M Seed · Oct 2026
GGravis Robotics$200M Series A · Aug 2026
MMindgard$30M Series A · Aug 2026
VValarian$50M Series A · Jul 2026
NNyobolt$60M Series B+ · May 2026
RRivan Industries$33.77M Series A · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/imu-biosciences (get a free API key).